Novartis defeats UK court bid to invalidate blockbuster drug Entresto patent
LONDON, Aug 13 (Reuters) – Swiss drugmaker Novartis on Thursday defeated a bid to invalidate its patent for blockbuster heart drug Entresto, with London’s High Court rejecting a claim by Intas Pharmaceuticals’ Accord Healthcare which was planning a generic rival. The ruling is a boost for Novartis as it navigates a busy period of patent expiries including for Entresto, which makes up about 10% of Novartis’ sales. Novartis’ European patent […]